Horizon Discovery Appoints Richard Vellacott as Chief Financial Officer
Horizon Discovery Limited has announced the appointment of Mr. Richard Vellacott as Chief Financial Officer.
Richard has over 15 years’ experience in working with life science companies, from start-ups to global pharmaceuticals, and is a chartered accountant with a first class degree in Biological Sciences from the University of Durham. Prior to joining Horizon, Richard was Vice President, Finance at CSR plc, a listed hi-tech company with revenues of $1bn. During his time at CSR, Richard had worldwide responsibility for finance, making significant contributions to the transformational acquisition and integration of NASDAQ listed Zoran Corp., product portfolio management, R&D budgeting and business investment / divestment decisions. Before this, Richard was a Director in Deloitte’s life sciences practice, where he specialized in capital market transactions including IPOs, M&A and fundraising on both the UK and the US markets.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.